港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

科伦博泰生物-B

467.800

-2.000-0.43%

成交量：43.19万

成交额：2.04亿

市值：1,089.97亿

市盈率：-356.17

高：488.000

开：478.000

低：462.600

收：469.800

52周最高：488.000

52周最低：152.000

股本：2.33亿

香港流通股本：1.63亿

量比：0.89

换手率：0.26%

股息：- -

股息率：- -

每股收益(LYR):-1.313

净资产收益率：-17.56%

总资产收益率：-10.17%

市净率：19.92

市盈率(LYR):-356.17

市销率: 66.56

数据加载中...

总览公司新闻公告

创新药概念部分逆市上扬康诺亚-B(02162)涨超3% 机构看好2025年研发催化与集采出清机遇

港股概念追踪 | MSCI指数调整明日盘后生效！科技股等或迎增量资金外资集体看多中国资产(附概念股)

招银国际：升科伦博泰生物-B(06990)目标价至498.55港元续吁买入

港股收盘恒生指数跌0.24%恒生科技指数跌0.77%。港股科技ETF（159751）跌0.97%恒生港股通ETF（159

异动解读 | 科伦博泰生物-B盘中大涨5.06%，中金上调目标价至550港元

中金：维持科伦博泰生物-B(06990)跑赢行业评级升目标价至550港元

【券商聚焦】交银国际维持科伦博泰生物(06990)买入评级指其上半年业绩基本符合预期

美银证券：升科伦博泰生物-B(06990)目标价至471.5港元临床进展符合预期

香港金管局持续回收港元流动性生物医药股继续调整同源康医药-B(02410)跌24.63%

《大行》野村降科伦博泰生物(06990.HK)评级至“中性” 目标价升至434.36元

阿斯达克财经

《大行》花旗上调科伦博泰(06990.HK)目标价至560元升SKB264销售预测

阿斯达克财经

科伦博泰生物－Ｂ(06990)出现大手买入1.26万股，成交价$459.6，涉资579.096万

阿斯达克财经

《大行》里昂升科伦博泰(06990.HK)目标价至500.6元上半年业绩胜预期

阿斯达克财经

异动解读 | 科伦博泰生物-B股价盘中大涨6.36%，生物医药板块整体走强

中信里昂：升科伦博泰生物-B(06990)目标价至500.6港元重申“跑赢大市”评级

港股异动 | 科伦博泰生物-B(06990.HK)绩后涨超3% 中期收入9.5亿元预期下半年于国内推出舒泰莱®

港股生物医药B类股盘初活跃，创胜集团涨超14%，绿竹生物涨近10%

老虎资讯综合

科伦博泰生物-B(06990)中报观：商业化确定性拉升，全球创新价值再上台阶

科伦博泰生物-B(06990)发布中期业绩，收入9.5亿元研发开支6.12亿元

国金证券：从IL-2双抗看TAA、细胞及趋化因子的PD-1升级新方向

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/06990/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"06990","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","market":"HK","secType":"STK","nameCN":"科伦博泰生物-B","latestPrice":467.8,"timestamp":1756186915228,"preClose":469.8,"halted":0,"volume":431948,"delay":0,"floatShares":163000000,"shares":233000000,"eps":-1.3134296791679358,"marketStatus":"交易中","change":-2,"latestTime":"08-26 13:42:08","open":478,"high":488,"low":462.6,"amount":203563002,"amplitude":0.054066,"askPrice":467.8,"askSize":400,"bidPrice":467.4,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.494446536110005,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1756195800000},"marketStatusCode":2,"adr":0,"listingDate":1689004800000,"exchange":"SEHK","adjPreClose":469.8,"openAndCloseTimeList":[[1756171800000,1756180800000],[1756184400000,1756195200000]],"volumeRatio":0.889868,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","floatShares":163000000,"roa":"-10.17%","roe":"-17.56%","lyrEps":-1.31343,"volumeRatio":0.889868,"shares":233000000,"dividePrice":0,"high":488,"amplitude":0.054066,"preClose":469.8,"low":462.6,"week52Low":152,"pbRate":"19.92","psRate":"66.56","week52High":488,"institutionHeld":0,"latestPrice":467.8,"committee":-0.6,"eps":-1.3134296791679358,"divideRate":0,"volume":431948,"delay":0,"ttmEps":-3.494446536110005,"open":478,"prevYearClose":163.3,"prevWeekClose":466.6,"prevMonthClose":416,"prevQuarterClose":327.2,"fiveDayClose":456,"twentyDayClose":394.2,"sixtyDayClose":319},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06990\",params:#limit:5,,,undefined,":[{"date":"2025-08-18","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755480600000,"name":null,"time":"","dateTimestamp":1755446400000,"actualEps":null},{"date":"2025-03-24","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"盘后","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-19","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"盘后","dateTimestamp":1723996800000,"actualEps":null},{"date":"2024-03-25","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null},{"date":"2023-08-28","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693186200000,"name":null,"time":"","dateTimestamp":1693152000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06990\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06990\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3158,"buy":0.5789,"hold":0.1053,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5789,"analysts":19,"updateTime":1755878400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06990\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06990","date":"2025-08-25","current":-136.101797,"percent":0.466667,"low":-351.800852,"twenty":-221.577452,"median":-78.525688,"eighty":-47.429017,"high":-21.029201,"avg":-125.278833,"sd":86.193443,"marketCap":107369867374},"quantilePoints":[{"date":"2023-07-14","current":-21.13661,"twenty":-21.950454,"median":-21.915957,"eighty":-21.591449,"marketCap":14244687534},{"date":"2023-07-21","current":-23.970152,"twenty":-21.950454,"median":-21.798359,"eighty":-21.186829,"marketCap":16079230625},{"date":"2023-07-28","current":-25.171471,"twenty":-24.928642,"median":-21.953758,"eighty":-21.326081,"marketCap":16867005011},{"date":"2023-08-04","current":-23.795235,"twenty":-24.81024,"median":-23.425444,"eighty":-21.637654,"marketCap":15971316326},{"date":"2023-08-11","current":-25.354634,"twenty":-24.81024,"median":-23.323535,"eighty":-21.856149,"marketCap":16921892522},{"date":"2023-08-18","current":-27.290696,"twenty":-25.136334,"median":-23.811022,"eighty":-21.920213,"marketCap":18083628667},{"date":"2023-08-25","current":-27.955027,"twenty":-25.91111,"median":-24.066367,"eighty":-21.957062,"marketCap":18532979440},{"date":"2023-09-01","current":-41.23344,"twenty":-27.36684,"median":-24.766756,"eighty":-21.989236,"marketCap":16768455673},{"date":"2023-09-08","current":-41.179226,"twenty":-40.625811,"median":-24.994187,"eighty":-22.159386,"marketCap":16549260174},{"date":"2023-09-15","current":-42.756679,"twenty":-41.200358,"median":-25.354634,"eighty":-22.761005,"marketCap":17316444421},{"date":"2023-09-22","current":-42.808543,"twenty":-42.12743,"median":-25.915972,"eighty":-23.169807,"marketCap":17261645546},{"date":"2023-09-29","current":-41.568511,"twenty":-42.347449,"median":-27.197776,"eighty":-23.343916,"marketCap":16790375223},{"date":"2023-10-06","current":-41.914184,"twenty":-42.346401,"median":-27.481057,"eighty":-23.57336,"marketCap":16921892522},{"date":"2023-10-13","current":-45.021843,"twenty":-42.393899,"median":-34.166325,"eighty":-23.80155,"marketCap":18149387317},{"date":"2023-10-20","current":-39.509362,"twenty":-42.529229,"median":-40.304828,"eighty":-23.874674,"marketCap":15902633452},{"date":"2023-10-27","current":-41.923505,"twenty":-42.45246,"median":-40.317099,"eighty":-23.977981,"marketCap":16867093648},{"date":"2023-11-03","current":-44.17615,"twenty":-43.157759,"median":-40.968576,"eighty":-24.032126,"marketCap":17820594068},{"date":"2023-11-10","current":-48.451746,"twenty":-43.729096,"median":-41.213927,"eighty":-24.147781,"marketCap":19541278735},{"date":"2023-11-17","current":-48.422639,"twenty":-44.163404,"median":-41.246315,"eighty":-24.349478,"marketCap":19705675360},{"date":"2023-11-24","current":-47.973827,"twenty":-44.628759,"median":-41.529173,"eighty":-24.780872,"marketCap":19683755810},{"date":"2023-12-01","current":-50.941262,"twenty":-45.174782,"median":-41.90853,"eighty":-24.844962,"marketCap":20987969029},{"date":"2023-12-08","current":-50.880899,"twenty":-46.685504,"median":-41.9817,"eighty":-24.922954,"marketCap":20878371279},{"date":"2023-12-15","current":-53.058458,"twenty":-47.438439,"median":-42.172758,"eighty":-25.124621,"marketCap":21897630350},{"date":"2023-12-22","current":-55.272951,"twenty":-48.26932,"median":-42.355666,"eighty":-25.208104,"marketCap":22796331896},{"date":"2023-12-29","current":-54.398289,"twenty":-48.483234,"median":-42.389893,"eighty":-25.318001,"marketCap":22555216847},{"date":"2024-01-05","current":-54.305497,"twenty":-48.692055,"median":-42.518207,"eighty":-25.505631,"marketCap":22357940898},{"date":"2024-01-12","current":-58.852865,"twenty":-49.706536,"median":-42.808543,"eighty":-25.777515,"marketCap":24243022189},{"date":"2024-01-19","current":-48.649703,"twenty":-50.614438,"median":-43.44751,"eighty":-25.920835,"marketCap":20012549058},{"date":"2024-01-26","current":-45.202208,"twenty":-50.432693,"median":-43.523908,"eighty":-26.320623,"marketCap":18522019665},{"date":"2024-02-02","current":-38.832469,"twenty":-50.323187,"median":-43.65215,"eighty":-26.948338,"marketCap":15891673677},{"date":"2024-02-09","current":-43.972121,"twenty":-49.706536,"median":-43.780393,"eighty":-27.253528,"marketCap":18083628667},{"date":"2024-02-16","current":-51.156498,"twenty":-50.095577,"median":-43.99523,"eighty":-27.328768,"marketCap":21042767904},{"date":"2024-02-23","current":-57.052501,"twenty":-50.855188,"median":-44.095348,"eighty":-27.575851,"marketCap":23344320643},{"date":"2024-03-01","current":-55.517903,"twenty":-51.144997,"median":-44.174132,"eighty":-27.979787,"marketCap":22730573246},{"date":"2024-03-08","current":-62.556972,"twenty":-52.587613,"median":-44.308071,"eighty":-30.229554,"marketCap":25623953833},{"date":"2024-03-15","current":-80.340969,"twenty":-54.14227,"median":-44.794506,"eighty":-38.844663,"marketCap":32879324850},{"date":"2024-03-22","current":-87.812662,"twenty":-54.39157,"median":-45.089055,"eighty":-38.957109,"marketCap":35904222736},{"date":"2024-03-28","current":-54.646477,"twenty":-54.498503,"median":-45.202208,"eighty":-39.211798,"marketCap":33975302345},{"date":"2024-04-05","current":-48.790889,"twenty":-54.557693,"median":-45.399289,"eighty":-39.390336,"marketCap":30314737511},{"date":"2024-04-12","current":-51.407626,"twenty":-54.48688,"median":-46.006494,"eighty":-39.95604,"marketCap":31958703754},{"date":"2024-04-19","current":-48.134373,"twenty":-54.430626,"median":-46.386128,"eighty":-40.284427,"marketCap":29898266063},{"date":"2024-04-26","current":-71.709655,"twenty":-54.881886,"median":-46.751052,"eighty":-40.312191,"marketCap":36824843832},{"date":"2024-05-03","current":-70.050704,"twenty":-55.277405,"median":-46.894686,"eighty":-40.440284,"marketCap":35948061836},{"date":"2024-05-10","current":-80.537958,"twenty":-55.535893,"median":-47.299854,"eighty":-40.706984,"marketCap":41427949311},{"date":"2024-05-17","current":-72.846762,"twenty":-56.640749,"median":-47.434905,"eighty":-40.885351,"marketCap":37416671679},{"date":"2024-05-24","current":-76.490072,"twenty":-57.838988,"median":-47.480121,"eighty":-41.121673,"marketCap":39198277014},{"date":"2024-05-31","current":-74.804992,"twenty":-59.45269,"median":-48.0541,"eighty":-41.186166,"marketCap":38373753847},{"date":"2024-06-07","current":-77.551054,"twenty":-62.567703,"median":-48.422639,"eighty":-41.217553,"marketCap":39733102851},{"date":"2024-06-14","current":-71.048454,"twenty":-63.220056,"median":-48.609184,"eighty":-41.232055,"marketCap":36368156956},{"date":"2024-06-21","current":-75.38559,"twenty":-65.709636,"median":-48.654461,"eighty":-41.23344,"marketCap":38507460307},{"date":"2024-06-28","current":-72.361795,"twenty":-70.050704,"median":-48.790889,"eighty":-41.25919,"marketCap":36947551614},{"date":"2024-07-05","current":-71.32983,"twenty":-70.110492,"median":-48.913989,"eighty":-41.293743,"marketCap":36412725776},{"date":"2024-07-12","current":-64.338068,"twenty":-69.786991,"median":-49.290918,"eighty":-41.483815,"marketCap":32891789012},{"date":"2024-07-19","current":-64.816339,"twenty":-69.10708,"median":-50.290098,"eighty":-41.560643,"marketCap":33136917521},{"date":"2024-07-26","current":-64.836994,"twenty":-68.943217,"median":-50.396598,"eighty":-41.836002,"marketCap":33270623980},{"date":"2024-08-02","current":-67.177788,"twenty":-68.832021,"median":-50.583009,"eighty":-41.911922,"marketCap":34451697705},{"date":"2024-08-09","current":-67.337335,"twenty":-68.832021,"median":-50.91108,"eighty":-41.921641,"marketCap":34763679444},{"date":"2024-08-16","current":-69.468586,"twenty":-68.832021,"median":-51.098991,"eighty":-41.970061,"marketCap":35877899939},{"date":"2024-08-23","current":-143.952492,"twenty":-69.519081,"median":-51.282062,"eighty":-42.023931,"marketCap":36568716645},{"date":"2024-08-30","current":-142.905377,"twenty":-70.543671,"median":-51.775379,"eighty":-42.069838,"marketCap":36546432236},{"date":"2024-09-06","current":-147.713941,"twenty":-71.622574,"median":-52.451442,"eighty":-42.229208,"marketCap":37794359190},{"date":"2024-09-13","current":-159.71572,"twenty":-72.235174,"median":-53.058458,"eighty":-42.319371,"marketCap":40758185707},{"date":"2024-09-20","current":-153.295015,"twenty":-72.624329,"median":-53.663008,"eighty":-42.346401,"marketCap":39354267883},{"date":"2024-09-27","current":-152.378595,"twenty":-73.54444,"median":-54.299669,"eighty":-42.364187,"marketCap":39354267883},{"date":"2024-10-04","current":-188.785359,"twenty":-74.133327,"median":-54.381491,"eighty":-42.385888,"marketCap":48535444762},{"date":"2024-10-10","current":-168.292174,"twenty":-74.96999,"median":-54.488817,"eighty":-42.420555,"marketCap":42986626697},{"date":"2024-10-18","current":-169.261982,"twenty":-75.395206,"median":-54.742682,"eighty":-42.48514,"marketCap":43008911107},{"date":"2024-10-25","current":-173.131782,"twenty":-76.300948,"median":-55.181976,"eighty":-42.60999,"marketCap":43989425142},{"date":"2024-11-01","current":-155.135166,"twenty":-77.964709,"median":-55.298647,"eighty":-42.767052,"marketCap":39443405523},{"date":"2024-11-08","current":-154.553256,"twenty":-78.843611,"median":-55.532894,"eighty":-42.819467,"marketCap":38997717325},{"date":"2024-11-15","current":-143.716763,"twenty":-80.792913,"median":-56.569783,"eighty":-42.897746,"marketCap":35989321988},{"date":"2024-11-22","current":-149.571879,"twenty":-86.542136,"median":-57.071537,"eighty":-43.077872,"marketCap":37437808632},{"date":"2024-11-29","current":-163.214034,"twenty":-139.660525,"median":-57.926605,"eighty":-43.27892,"marketCap":40825038936},{"date":"2024-12-06","current":-164.492389,"twenty":-143.07608,"median":-58.601892,"eighty":-43.427612,"marketCap":41047883035},{"date":"2024-12-13","current":-167.859925,"twenty":-143.961595,"median":-59.46824,"eighty":-43.489321,"marketCap":41805552972},{"date":"2024-12-20","current":-160.518216,"twenty":-146.054141,"median":-61.493522,"eighty":-43.569737,"marketCap":39799956081},{"date":"2024-12-27","current":-154.616488,"twenty":-147.398806,"median":-62.556972,"eighty":-43.707223,"marketCap":38306900618},{"date":"2025-01-03","current":-146.467928,"twenty":-147.580179,"median":-62.909234,"eighty":-43.769457,"marketCap":36323588137},{"date":"2025-01-10","current":-149.189796,"twenty":-147.713941,"median":-63.270129,"eighty":-43.89543,"marketCap":36858413974},{"date":"2025-01-17","current":-146.545949,"twenty":-148.128618,"median":-63.821936,"eighty":-43.999852,"marketCap":36234450497},{"date":"2025-01-24","current":-151.096908,"twenty":-148.795989,"median":-64.223738,"eighty":-44.022873,"marketCap":37593799501},{"date":"2025-01-28","current":-144.751587,"twenty":-148.750633,"median":-64.3181,"eighty":-44.025895,"marketCap":36203787461},{"date":"2025-02-07","current":-162.755483,"twenty":-148.864023,"median":-64.816339,"eighty":-44.095348,"marketCap":40476425278},{"date":"2025-02-14","current":-166.856795,"twenty":-150.654332,"median":-65.202788,"eighty":-44.112421,"marketCap":41476404342},{"date":"2025-02-21","current":-194.414734,"twenty":-151.676932,"median":-65.382992,"eighty":-44.172115,"marketCap":48498984584},{"date":"2025-02-28","current":-211.14481,"twenty":-152.24965,"median":-65.712478,"eighty":-44.17615,"marketCap":52498900839},{"date":"2025-03-07","current":-225.41295,"twenty":-152.905086,"median":-66.309677,"eighty":-44.219461,"marketCap":56271549124},{"date":"2025-03-14","current":-227.151092,"twenty":-153.295015,"median":-66.812487,"eighty":-44.308071,"marketCap":56726085062},{"date":"2025-03-21","current":-236.708664,"twenty":-154.553256,"median":-67.337335,"eighty":-44.550078,"marketCap":59089671940},{"date":"2025-03-28","current":-231.805328,"twenty":-155.61149,"median":-67.803663,"eighty":-44.648429,"marketCap":66180441600},{"date":"2025-04-03","current":-246.46154,"twenty":-156.727441,"median":-67.952396,"eighty":-44.882152,"marketCap":70225812000},{"date":"2025-04-11","current":-242.489155,"twenty":-158.779779,"median":-68.515098,"eighty":-45.005591,"marketCap":68634936000},{"date":"2025-04-17","current":-228.611836,"twenty":-159.44307,"median":-68.80487,"eighty":-45.06217,"marketCap":64862287200},{"date":"2025-04-25","current":-235.137362,"twenty":-160.624501,"median":-68.953584,"eighty":-45.131919,"marketCap":66771338400},{"date":"2025-05-02","current":-274.570331,"twenty":-161.195254,"median":-69.468586,"eighty":-45.197413,"marketCap":78134738400},{"date":"2025-05-09","current":-249.374354,"twenty":-161.514906,"median":-70.050704,"eighty":-45.202208,"marketCap":71462875059},{"date":"2025-05-16","current":-247.507619,"twenty":-162.87029,"median":-70.732965,"eighty":-45.217068,"marketCap":71507400214},{"date":"2025-05-23","current":-244.618313,"twenty":-163.824551,"median":-71.32983,"eighty":-45.58151,"marketCap":70884048033},{"date":"2025-05-30","current":-244.159494,"twenty":-165.025774,"median":-71.669987,"eighty":-45.601984,"marketCap":71062148656},{"date":"2025-06-06","current":-258.187076,"twenty":-166.004403,"median":-72.203519,"eighty":-46.006494,"marketCap":75336563613},{"date":"2025-06-13","current":-271.678883,"twenty":-167.701589,"median":-72.488214,"eighty":-46.133909,"marketCap":79304691313},{"date":"2025-06-20","current":-252.757485,"twenty":-168.349452,"median":-72.789206,"eighty":-46.315126,"marketCap":73636805593},{"date":"2025-06-27","current":-255.806605,"twenty":-169.647858,"median":-73.569836,"eighty":-46.457129,"marketCap":74733815733},{"date":"2025-07-04","current":-283.173205,"twenty":-171.495185,"median":-73.869687,"eighty":-46.685504,"marketCap":82732847998},{"date":"2025-07-11","current":-266.231967,"twenty":-173.142078,"median":-74.539848,"eighty":-46.749361,"marketCap":77704884860},{"date":"2025-07-18","current":-304.526119,"twenty":-187.755426,"median":-75.01675,"eighty":-46.798833,"marketCap":88812112519},{"date":"2025-07-25","current":-289.211949,"twenty":-196.095673,"median":-75.38559,"eighty":-46.877904,"marketCap":84652615741},{"date":"2025-08-01","current":-318.351212,"twenty":-209.071662,"median":-75.715906,"eighty":-46.908544,"marketCap":92605939250},{"date":"2025-08-08","current":-315.832709,"twenty":-214.487876,"median":-76.34536,"eighty":-47.149906,"marketCap":92103142937},{"date":"2025-08-15","current":-340.637946,"twenty":-221.73884,"median":-77.157567,"eighty":-47.354138,"marketCap":99188000086},{"date":"2025-08-22","current":-135.707825,"twenty":-221.73884,"median":-78.335478,"eighty":-47.421279,"marketCap":106638527281},{"date":"2025-08-25","current":-136.101797,"twenty":-221.577452,"median":-78.525688,"eighty":-47.429017,"marketCap":107369867374}],"updateTime":1756186928902},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06990\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2562270073","title":"创新药概念部分逆市上扬 康诺亚-B(02162)涨超3% 机构看好2025年研发催化与集采出清机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2562270073","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562270073?lang=zh_cn&edition=fundamental","pubTime":"2025-08-26 10:03","pubTimestamp":1756173802,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念部分逆市上扬，康诺亚-B 涨3.02%，云顶新耀涨2.97%，欧康维视生物-B涨2.29%，博安生物涨2.50%，巨子生物涨2.39%，同源康医药-B涨1.98%，歌礼制药-B涨2.24%，科伦博泰生物-B涨1.32%，翰森制药涨1.33%。国元证券指出，目前中报已经临近尾声，市场也将逐步的从关注中报业绩转移到新的方向，2025年下半年继续看好创新药、出海以及集采出清板块。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210810/ZTUyNTQ0NjcxODUwNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZTUyNTQ0NjcxODUwNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1964821","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999004311.SGD","BK1515","BK1574","LU2488822045.USD","BK1191","159992","03692","06990","LU0196878994.USD","02410","02162","BK1583","01477","BK1161","02367","BK1587","06978","BK1589","01672","01952","06955","BK1207"],"gpt_icon":0},{"id":"2562921373","title":"港股概念追踪 | MSCI指数调整明日盘后生效！科技股等或迎增量资金 外资集体看多中国资产(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2562921373","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562921373?lang=zh_cn&edition=fundamental","pubTime":"2025-08-25 14:27","pubTimestamp":1756103249,"startTime":"0","endTime":"0","summary":"本次调整将于8月26日收盘后生效。公开资料显示，MSCI系列指数在国际资本市场具有较强影响力。市场人士表示，市场普遍关注8月26日收盘后生效带来的被动资金效应。由于MSCI中国指数同时被纳入MSCI新兴市场指数，新成分股有望在收盘后迎来海外指数基金集中配置，尾盘成交或出现放量。外资机构集体唱多在MSCI指数调整的同时，国际评级机构与外资巨头纷纷释放对中国资产的积极信号。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1334343.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09899","IE0009570106.USD","BK4112","BK4588","LU0320765059.SGD","HSTECH","BK1161","TTTN","BK1147","LU0289961442.SGD","BK4614","LU0511384066.AUD","BK1615","LU2210149790.SGD","LU2265009873.SGD","06990","BK4585","03086","LU0289739343.SGD","BK1593","BK1128","LU2210150020.SGD","HSCEI","LU0175139822.USD","LU2095319765.USD","LU0231459107.USD","01530","LU1267930730.SGD","MSCI","LU0278937759.USD","LU0196878994.USD","IE00BKPKM429.USD","LU1804176565.USD","YANG","LU0289960550.SGD","LU0708995401.HKD","LU0109391861.USD","BK1583","LU0672654240.SGD"],"gpt_icon":1},{"id":"2561042114","title":"招银国际：升科伦博泰生物-B(06990)目标价至498.55港元 续吁买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2561042114","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561042114?lang=zh_cn&edition=fundamental","pubTime":"2025-08-22 15:44","pubTimestamp":1755848694,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，招银国际发布研报称，对科伦博泰生物-BSKB264的全球发展保持信心，将目标价由299.93港元上调至498.55港元，此按现金流折现率作估值，维持“买入”评级。科伦博泰生物上半年收入9.5亿元人民币(下同)，期内产品销售额达3.1亿元人民币，当中SKB264贡献3.02亿元，相当于该行全年预测的34%。管理层维持SKB264全年销售额8至10亿元的目标。销售开支占销售额比例为58%，反映SKB264获批后开展商业活动。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1333435.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06990"],"gpt_icon":0},{"id":"2561245298","title":"港股收盘恒生指数跌0.24%恒生科技指数跌0.77%。港股科技ETF（159751）跌0.97%恒生港股通ETF（159","url":"https://stock-news.laohu8.com/highlight/detail?id=2561245298","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561245298?lang=zh_cn&edition=fundamental","pubTime":"2025-08-21 16:10","pubTimestamp":1755763801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MCHmain","BK0012","02333","REIT","06869","159751","159227","BK1586","BK1580","LU1328615791.USD","YANG","01833","BK0264","000063","HSImain","MHImain","07226","BK1142","601766","01766","159837","BK0006","01801","01860","159318","LU1064130708.USD","06969","BK1515","601633","BK1583","513020","82333","BK0055","BK1219","02833","CFA.SI","BK0214","HSTECH","00763","513990","BK1137","HSCEI","02232","513600","HHImain","BK1565","06990","HSI","GWLLY","159271"],"gpt_icon":0},{"id":"1152690653","title":"异动解读 | 科伦博泰生物-B盘中大涨5.06%，中金上调目标价至550港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1152690653","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152690653?lang=zh_cn&edition=fundamental","pubTime":"2025-08-21 15:34","pubTimestamp":1755761674,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B今日盘中大涨5.06%，引发市场关注。股价上涨主要受到多家券商发布积极研报的推动，其中中金公司大幅上调了公司的目标价。中金公司发布研报维持科伦博泰生物-B\"跑赢行业\"评级，并将目标价上调57.1%至550港元，较当前股价有20.6%的上行空间。此外，交银国际也发布研报，维持科伦博泰生物\"买入\"评级，目标价上调至507港元。分析人士认为，科伦博泰生物-B股价的强势表现反映了投资者对公司业绩增长和产品管线发展的信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["06990"],"gpt_icon":0},{"id":"2561437464","title":"中金：维持科伦博泰生物-B(06990)跑赢行业评级 升目标价至550港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2561437464","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561437464?lang=zh_cn&edition=fundamental","pubTime":"2025-08-21 11:50","pubTimestamp":1755748259,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中金发布研报称，由于科伦博泰生物-B授权收入确认和费用管控良好，维持跑赢行业评级，考虑到盈利预测上调，叠加研发进展催化兑现，根据DCF模型，上调目标价57.1%至550港币，较当前股价有20.6%的上行空间。公司公布1H25业绩，收入9.50亿元，超该行预期。该行认为佳泰莱目前在获批适应症TNBC、3L NSCLC临床获益证据明确，随着下半年有望在国内获批2L NSCLC及积极2026推进医保准入工作，未来有望进一步放量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1332628.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06990"],"gpt_icon":0},{"id":"2561434315","title":"【券商聚焦】交银国际维持科伦博泰生物(06990)买入评级 指其上半年业绩基本符合预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2561434315","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561434315?lang=zh_cn&edition=fundamental","pubTime":"2025-08-21 10:21","pubTimestamp":1755742911,"startTime":"0","endTime":"0","summary":"管理层表示将于2025年ESMO大会上公布两项三期临床数据，包括：1）2L HR+/HER2-乳腺癌适应症；2）二线EGFRmt NSCLC适应症。此外，公司多项早期管线稳步推进：SKB571即将进入二期临床，联用潜力充足，有望布局消化道肿瘤等与芦康沙妥珠具有差异化的适应症。基于DCF模型，该机构上调公司目标价至507港元，维持买入评级。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1964517","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"gpt_icon":0},{"id":"2560117656","title":"美银证券：升科伦博泰生物-B(06990)目标价至471.5港元 临床进展符合预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2560117656","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560117656?lang=zh_cn&edition=fundamental","pubTime":"2025-08-20 17:06","pubTimestamp":1755680808,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，美银证券发布研报称，科伦博泰生物-B(06990)核心资产SKB264在多项适应症中取得稳定进展，该行提高其临床阶段适应症的成功概率，从而推高各相应适应症的高峰销售额预估，并据公司中期业绩提高今年合作收入预测。该行对科伦博泰目标价由340港元上调至471.5港元，认为其资产的临床进展符合预期。该行上调公司今年至2027年收入预测1%至6%，并按中期业绩利润率调整全年毛利率预测，基于公司胜预期的营运效率，下调对公司今年至2027年销售费用和研发费用预估。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1332147.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06990","161027"],"gpt_icon":0},{"id":"2560128352","title":"香港金管局持续回收港元流动性 生物医药股继续调整 同源康医药-B(02410)跌24.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560128352","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560128352?lang=zh_cn&edition=fundamental","pubTime":"2025-08-20 11:00","pubTimestamp":1755658801,"startTime":"0","endTime":"0","summary":"中泰国际表示，随着香港金管局持续回收港元流动性，当前一个月HIBOR回升至2.57%的两个月高位，港美利差快速收窄至1.76%，沽港元买美元的套息交易平仓，导致港汇快速转强。港元资金成本上升直接影响企业融资及投资者的保证金借贷成本，或导致投资者使用杠杆的意欲下降。对于流动性较敏感的生物医药、未有盈利的科技股、本地地产股将面临借势调整压力。","market":"hk","thumbnail":"https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1964420","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410","BK1515","LU0348784397.USD","BK1583","BK1191","399441","IE00B543WZ88.USD","02157","161726","02162","LU1720050803.USD","03692","159938","09926","LU0348783233.USD","IE00B5MMRT66.SGD","06990","BK1161","02186","BK1574","LU0196878994.USD","06955","BK1606","LU1794554557.SGD","09969","09939","BK1589","LU0417516571.SGD","BK1587","IE00BPRC5H50.USD","LU2488822045.USD"],"gpt_icon":0},{"id":"2560400441","title":"《大行》野村降科伦博泰生物(06990.HK)评级至“中性”  目标价升至434.36元","url":"https://stock-news.laohu8.com/highlight/detail?id=2560400441","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560400441?lang=zh_cn&edition=fundamental","pubTime":"2025-08-20 10:49","pubTimestamp":1755658140,"startTime":"0","endTime":"0","summary":"野村发表报告，将科伦博泰生物-B评级由“买入”降至“中性”，目标价就由211.87元大幅升至434.36元。报告指，科伦博泰生物上半年收入按年下降31.3%至9.5亿元人民币(下同)，超出市场预期5%。因此上半年净亏损为1.45亿元，相比2024年上半年净利润3.1亿元。截至2025年上半年末，公司持有现金及金融资产45.3亿元，相较于2024年财年末的30.6亿元，部分得益于2025年6月新股发行，募集资金约17.5亿元。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230628160649432_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230628160649432_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1462494/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["06990"],"gpt_icon":0},{"id":"2560147476","title":"《大行》花旗上调科伦博泰(06990.HK)目标价至560元 升SKB264销售预测","url":"https://stock-news.laohu8.com/highlight/detail?id=2560147476","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560147476?lang=zh_cn&edition=fundamental","pubTime":"2025-08-20 10:13","pubTimestamp":1755655980,"startTime":"0","endTime":"0","summary":"花旗研究报告指，科伦博泰上半年收入达9.5亿元人民币(下同)，当中包括销售收入3.1亿元，净亏损1.45亿元。销售开支为1.79亿元，研发开支按年降6%至6.12亿元。SKB264产品上半年销售额达约3.02亿元，管理层目标全年销售额达8亿至10亿元。公司将于欧洲肿瘤内科学会年会上公布SKB264两项国内第三阶段研究数据，该行预期数据将进一步验证其同类最优潜力。(港股报价延迟最少十五分钟。沽空资料截至 2025-08-19 16:25。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230904161537733_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230904161537733_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1462481/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["06990"],"gpt_icon":0},{"id":"2560514279","title":"科伦博泰生物－Ｂ(06990)出现大手买入1.26万股，成交价$459.6，涉资579.096万","url":"https://stock-news.laohu8.com/highlight/detail?id=2560514279","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560514279?lang=zh_cn&edition=fundamental","pubTime":"2025-08-20 09:45","pubTimestamp":1755654300,"startTime":"0","endTime":"0","summary":"[大手成交]科伦博泰生物－Ｂ(06990)在上午09:45出现大手买入，成交量为1.26万，成交价为港币$459.6，涉资579.096万。至目前为止，股价升0.395%，今日最高价为$459.6，而最低价为$443.0，总成交量为6.57万股，总成交金额港币$2.975千万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126132515779_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126132515779_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2508202574/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"2560689391","title":"《大行》里昂升科伦博泰(06990.HK)目标价至500.6元 上半年业绩胜预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2560689391","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560689391?lang=zh_cn&edition=fundamental","pubTime":"2025-08-19 14:22","pubTimestamp":1755584520,"startTime":"0","endTime":"0","summary":"里昂研究报告指，科伦博泰生物-B上半年收入按年跌31.3%，净亏损1.45亿元人民币(下同)，均好过市场预期。该行将科伦博泰生物2025至2027年的销售预测分别上调5.3%、2.7%及2.3%，净利润预测分别下调20.2%、上调34.2%及上调21.9%。里昂将科伦博泰生物目标价由328.4港元升至500.6港元，重申“跑赢大市”评级。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230628160655871_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230628160655871_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1462200/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["06990"],"gpt_icon":0},{"id":"1123453003","title":"异动解读 | 科伦博泰生物-B股价盘中大涨6.36%，生物医药板块整体走强","url":"https://stock-news.laohu8.com/highlight/detail?id=1123453003","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123453003?lang=zh_cn&edition=fundamental","pubTime":"2025-08-19 10:32","pubTimestamp":1755570765,"startTime":"0","endTime":"0","summary":"港股科伦博泰生物-B今日盘中大涨6.36%，引发市场关注。截至上午9点48分，该股报价已达到高点。本次涨势是在港股生物医药B类股整体活跃的背景下发生的。同一时间段内，创胜集团涨幅超过14%，绿竹生物涨近10%，启明医疗和来凯医药等多只生物医药股均有不同程度上涨。这表明投资者对生物医药板块整体保持乐观态度。值得注意的是，科伦博泰生物-B于8月18日发布了2025年上半年财报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3b0d46becfc3f8e56b058c8ed9fb2c6a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["06990"],"gpt_icon":0},{"id":"2560155514","title":"中信里昂：升科伦博泰生物-B(06990)目标价至500.6港元 重申“跑赢大市”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2560155514","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560155514?lang=zh_cn&edition=fundamental","pubTime":"2025-08-19 10:20","pubTimestamp":1755570011,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中信里昂发布研报称，根据最新数据调整了估值，基于折现现金流(DCF)，将科伦博泰生物-B(06990)目标价从328.4港元上调52%至500.6港元，并重申“跑赢大市”评级。报告指，集团首款中期产品销售额达3.1亿元人民币，主要得益于sac-TMT推动，二线非小细胞肺癌(NSCLC)的适应症扩展应能进一步支撑2025年下半年的销售额增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1331329.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06990"],"gpt_icon":0},{"id":"2560915399","title":"港股异动 | 科伦博泰生物-B(06990.HK)绩后涨超3% 中期收入9.5亿元 预期下半年于国内推出舒泰莱®","url":"https://stock-news.laohu8.com/highlight/detail?id=2560915399","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560915399?lang=zh_cn&edition=fundamental","pubTime":"2025-08-19 10:03","pubTimestamp":1755568986,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","06990","LU0196878994.USD"],"gpt_icon":0},{"id":"1116360898","title":"港股生物医药B类股盘初活跃，创胜集团涨超14%，绿竹生物涨近10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1116360898","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116360898?lang=zh_cn&edition=fundamental","pubTime":"2025-08-19 09:48","pubTimestamp":1755568113,"startTime":"0","endTime":"0","summary":"8月19日（周二），港股$生物(000504)$医药B类股盘初活跃，创胜集团涨超14%，绿竹生物涨近10%，$启明医疗(02500)$、$科伦博泰(06990)$生物涨超6%，$来凯医药(02105)$、和誉涨超4%。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3c69330474cfca501aba698b1d21b7cf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02500","07226","BK4614","06990","06628","BK1161","02480"],"gpt_icon":0},{"id":"2560906382","title":"科伦博泰生物-B(06990)中报观：商业化确定性拉升，全球创新价值再上台阶","url":"https://stock-news.laohu8.com/highlight/detail?id=2560906382","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560906382?lang=zh_cn&edition=fundamental","pubTime":"2025-08-18 18:12","pubTimestamp":1755511953,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B正是市场抢筹的核心标的之一——其股价于8月创下历史新高，市值突破千亿港元，年内最高涨幅达192.40%，正式跻身港股生物创新药\"千亿俱乐部\"。作为一家具备投资确定性的标杆药企，科伦博泰2025年中报的核心信号在于：自主商业化已成为业绩增长的新引擎。自2022年起，科伦博泰与默沙东达成了三次重大合作，总金额创下中国创新药出海纪录，也为其铺就了广阔的海外市场版图。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1330998.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"2560197006","title":"科伦博泰生物-B(06990)发布中期业绩，收入9.5亿元  研发开支6.12亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2560197006","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560197006?lang=zh_cn&edition=fundamental","pubTime":"2025-08-18 17:01","pubTimestamp":1755507712,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科伦博泰生物-B 发布截至2025年6月30日止6个月的中期业绩，该集团取得收入人民币9.5亿元，同比减少31.3%;研发开支6.12亿元，同比减少6.3%;公司权益股东应占亏损1.45亿元;每股亏损0.64元。2025年上半年商业销售总额达3.098亿元。其中，佳泰莱 的销售占97.6%。我们是中国首批也是全球为数不多的建立内部开发ADC及新型偶联药物平台OptiDCTM的生物制药公司之一。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1330931.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"科伦博泰生物-B(06990)发布中期业绩，收入9.5亿元  研发开支6.12亿元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"2559608787","title":"国金证券：从IL-2双抗 看TAA、细胞及趋化因子的PD-1升级新方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2559608787","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559608787?lang=zh_cn&edition=fundamental","pubTime":"2025-08-13 16:55","pubTimestamp":1755075315,"startTime":"0","endTime":"0","summary":"从肿瘤抗原TAA到IL-2因子类加持PD-1升级的新分子，信达生物PD-1/IL-2在ASCO首次发布数据，在免疫耐受肺癌与黑色素瘤以及冷肿瘤肠癌3项适应症中皆取得靓丽早期数据。除了PD-1等免疫检测点抑制剂与抗TAA的组合，PD-1等与白介素、TGFβ等细胞因子的组合发力，以及对TME相关因子的开发或成为肿瘤免疫治疗领域下一个重要赛道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1329073.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2328871848.SGD","BK0201","LU0348784397.USD","IE00B5MMRT66.SGD","BK0012","BK1161","PD","BK0028","BK1583","LU1169589451.USD","BK4023","BK1589","BK1574","01801","600109","LU1794554557.SGD","LU2488822045.USD","BK0188","09926","LU0196878994.USD","IE00BPRC5H50.USD","LU1969619763.USD","BK0183","LU1720050803.USD","06990","IE00B543WZ88.USD","LU0417516571.SGD","LU1169590202.USD","LU0348783233.USD","BK0276"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":195,"code":"91000000","status":"200"}]}}